Navigation Links
Amarin Announces Financial Results for Fourth Quarter and Full Year 2007
Date:5/19/2008

tion

(non-cash) 865 470 5,001 2,201

Operating expenses 7,733 7,081 40,733 28,568

Categorized as follows:

Total research

& development 2,120 4,080 12,108 15,106

Total selling, general &

administrative 5,613 3,001 28,625 13,462

Total operating expenses 7,733 7,081 40,733 28,568

Total operating (loss) (7,733) (6,681) (40,733) (28,068)

Finance income (139) 1,533 1,882 3,344

Finance expense (183) - (183) (2,826)

(Loss) before taxes (8,055) (5,148) (39,034) (27,550)

Income tax credit 172 128 837 799

Net (loss) for the period (7,883) (5,020) (38,197) (26,751)

Weighted average shares -

basic* 11,013 8,833 9,784 8,234

Loss per share:

Basic (0.72) (0.57) (3.90) (3.25)

Diluted (0.72) (0.57) (3.90) (3.25)

* Weighted average shares are calculated taking into account a one-for-ten reverse stock split which took effect from January 18, 2008

Amarin Corporation plc

Period Ended 31 December 2007 (IFRS - UNAUDITED)

As at 31 December As at 31 December

2007 2006

$'000 $'000

1. Selected Balance Sheet Data

Assets

Non-current assets

Property, plant and equipment 595 314

Intangible fixed assets 19,916 9,636

Available for sale investment
'/>"/>

SOURCE Amarin Corporation Plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Amarin Secures Global Intellectual Property Rights for Lipid Programs
2. Amarin Appoints Dr. William Mason as Lead Independent Director
3. Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
4. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
5. Amarin Signs Agreement to Acquire Ester Neurosciences
6. Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference
7. Amarin Announces Initiation of Cardiovascular Development Strategy
8. Amarin to Present at 4th Annual Bio Investor Forum
9. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
10. Volcano Announces Acquisition of Novelis, Inc.
11. RainDance Announces Company Relocation and Manufacturing Startup
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Genedata, a leading provider of ... Genedata Screener ® version 13.0 at ELRIG Drug Discovery 2015. This latest version ... set of new capabilities. Screener now supports High Throughput Flow Cytometry (HT-Flow) and ...
(Date:9/1/2015)... , Sept. 1, 2015 Prostate ... death in American men. One in seven ... 233,000 new cases are diagnosed annually. That said, ... using a powerful new technique, MRI Fusion Biopsy, ... large cancer lesions, treating only the affected areas ...
(Date:9/1/2015)... MILWAUKEE , Sept. 1, 2015 ... Eric Floyd , Ph.D., MBA as Chief ... (DLSS).  In this newly created role, Dr. Floyd ... well as a portfolio of pre-commercial and post ... medical affairs and medical communications.  Dr. Floyd brings ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... diseases has been discovered by researchers at the Keck Graduate Institute and its ... untreatable diseases. , The findings were published online on August 27 by Scientific ...
Breaking Biology Technology:New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 2Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 4
... Thursday, February 21, 2008 at 5:00 ... pm (Beijing/Hong Kong), SHENYANG, China, Feb. 11 ... on researching,developing, manufacturing and marketing biopharmaceutical products, today,announced that ... and full year ended December 31, 2007 after the ...
... Instructions to Clinicians to Mitigate Risk of ... While Working to Identify Root Cause, DEERFIELD, Ill., Feb. ... January 2008 heparin sodium,injection 1,000 units/mL 10 and 30mL multi-dose ... a precautionary measure due to an,increase in reports of adverse ...
... Genome Engineering Technology to Bring New Choices, More Options to Global ... ... Iowa, and RESEARCH TRIANGLE PARK, N.C., Feb. 11,/PRNewswire- FirstCall/ -- DuPont ... collaboration to bring higher-yielding,agricultural products to the market faster. Terms of ...
Cached Biology Technology:3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008 2Baxter Provides Update on Heparin Reactions 2Baxter Provides Update on Heparin Reactions 3DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development 2
(Date:7/31/2015)... de 2015 BGI llevará a cabo la 10ª ... al 25 de octubre de 2015, en ... su décimo aniversario este año. Desde su inauguración en ... reuniones anuales más influyentes del mundo en los campos ... científicas más dinámicas, entusiastas y amenas. ICG-10 ...
(Date:7/31/2015)... 31 juillet 2015 La 10e Conférence ... sera organisée par le BGI du 22 au ... en Chine. La conférence célèbre ... en 2006, l,ICG est devenue l,une des réunions ... des « omiques » et c,est aussi la plus dynamique, ...
(Date:7/31/2015)... China , 31. Juli 2015 Die 10. ... wird von BGI veranstaltet und findet vom 22. ... China , statt. Die ... Seit ihrem Start 2006 ist die ICG weltweit ... „omik" geworden. Sie ist eines der dynamischsten, enthusiastischsten ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3
... 2013 After six years of anticipation, that rock star ... flower for its putrid odor has bloomed here, and ... Chemical Society (ACS), the world,s largest scientific society. It is ... ACS Office of Public Affairs, award-winning Digital Services Unit, focuses ...
... for selection of antibiotic resistant bacteria. This has ... reduce overall antibiotic consumption. Now, using methicillin resistant ... Laura Temime of the Conservatoire National des Arts ... reducing antibiotics consumption does not necessarily reduce resistance. ...
... a Celebration of African Australians Inc Award at ... "exceptional achievements and remarkable contributions to Australia, Africa ... leadership and community engagement by African Australians." ... at Sydney,s Garvan Institute of Medical Research, while ...
Cached Biology News:Antibiotic reduction campaigns do not necessarily reduce resistance 2Professor Vanessa Hayes awarded for exceptional Africa-related work 2Professor Vanessa Hayes awarded for exceptional Africa-related work 3
HNF-1 Purified Anti-Mouse, Anti-Rat, Anti-Rabbit, Anti-Human clone 2, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... Immunogen KLH-conjugated, synthetic peptide ... (RRGPHRNPG-PGDDDGQRSRSSS) of mouse p19ARF. ... amino acids 62-75. Clone 5-C3-1. ... evaluated by immunoblot. ...
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
Complete cell culture media with cytokines...
Biology Products: